The global Veterinary Zinc Bacitracin market is expected to be around US$ 168 Million by 2027 at a CAGR of 5.3 % in the given forecast period.
Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish grey-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, leptospiral, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.
Veterinary care or animal care has fully fledged raised demand within the past few years. Animal health, particularly cattle has gained key focus after human invasion of animal viruses. Increased food safety and related government policies have fuelled veterinary healthcare market globally. Additionally, there’s also a surge in regular check of pets within the developed countries.
The global Veterinary Zinc Bacitracin market is segregated on the basis of Type as 10% Zinc Bacitracin and 15% Zinc Bacitracin. Based on Application the global Veterinary Zinc Bacitracin market is segmented in Pigs, Cattle, Chicken, and Others.
The global Veterinary Zinc Bacitracin market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Veterinary Zinc Bacitracin market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Lifecome Biochemistry, Qilu Pharmaceutical, Orion Animal Nutrition, Vega Pharma, Tianjin Xinxing Veterinary Pharmaceutical, Zoetis, Ceva Corporate, Huvepharma, and others are among the major players in the global Veterinary Zinc Bacitracin market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Veterinary Zinc Bacitracin Market has been segmented as below:
Veterinary Zinc Bacitracin Market, By Type
Veterinary Zinc Bacitracin Market, By Application
Veterinary Zinc Bacitracin Market, By Region
Veterinary Zinc Bacitracin Market, By Company
The report covers:
Report Scope:
The global Veterinary Zinc Bacitracin market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Veterinary Zinc Bacitracin market share. Major industry players with significant revenue share include Lifecome Biochemistry, Qilu Pharmaceutical, Orion Animal Nutrition, Vega Pharma, Tianjin Xinxing Veterinary Pharmaceutical, Zoetis, Ceva Corporate, Huvepharma, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Veterinary Zinc Bacitracin Market, By Type
5.1 Introduction
5.2 10% Zinc Bacitracin
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 15% Zinc Bacitracin
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Veterinary Zinc Bacitracin Market, By Application
6.1 Introduction
6.2 Pigs
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Cattle
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Chicken
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Veterinary Zinc Bacitracin Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Veterinary Zinc Bacitracin, By Type
7.2.2 North America Veterinary Zinc Bacitracin, By Application
7.3 Europe
7.3.1 Europe Veterinary Zinc Bacitracin, By Type
7.3.2 Europe Veterinary Zinc Bacitracin, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Veterinary Zinc Bacitracin, By Type
7.4.2 Asia-Pacific Veterinary Zinc Bacitracin, By Application
7.5 Rest of the World
7.5.1 Rest of the World Veterinary Zinc Bacitracin, By Type
7.5.2 Rest of the World Veterinary Zinc Bacitracin, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Lifecome Biochemistry
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Qilu Pharmaceutical
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Orion Animal Nutrition
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Vega Pharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Tianjin Xinxing Veterinary Pharmaceutical
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Zoetis
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Ceva Corporate
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Huvepharma
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
The Veterinary Zinc Bacitracin Market has been segmented as below:
Veterinary Zinc Bacitracin Market, By Type
Veterinary Zinc Bacitracin Market, By Application
Veterinary Zinc Bacitracin Market, By Region
Veterinary Zinc Bacitracin Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
